Description
TGX-221 is an inhibitor of PI3Kβ. It exhibits high selectivity to clear cell renal cell carcinoma with VHL and SETD2 mutations. It also inhibits cell migration and invasion, and induces apoptosis in human glioblastoma cells.
Product Unit Size | Cost | Quantity | Stock |
---|
TGX-221 is an inhibitor of PI3Kβ. It exhibits high selectivity to clear cell renal cell carcinoma with VHL and SETD2 mutations. It also inhibits cell migration and invasion, and induces apoptosis in human glioblastoma cells.
Cas No. | 663619-89-4 |
---|---|
Formula | C21H24N4O2 |
Formula Wt. | 364.44 |
IUPAC Name | 9-(1-anilinoethyl)-7-methyl-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one |
Solubility | DMSO 12 mg/mL (32.92 mM) Water Insoluble Ethanol Insoluble |
Appearance | Light Yellow Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Feng C., Sun Y., PI3Kβ inhibitor TGX221 selectively inhibits renal cell carcinoma cells with both VHL and SETD2 mutations and links multiple pathways. Sci Rep. 5:9465 (2015). PMID: 25853938.
Yang X., Yang J., TGX-221 inhibits proliferation and induces apoptosis in human glioblastoma cells. Oncol Rep. 38(5):2836-2842. PMID: 29048665.